Latest Revenue Guidance News

FINEOS Corporation Holdings PLC reported its strongest quarterly cash inflow ever alongside key contract wins in Australia and North America, maintaining its FY26 revenue guidance and advancing AI integration in its insurance software platform.

Pureprofile delivered a robust Q3 FY26 with 17% revenue growth and a 67% spike in EBITDA, driven by strong international demand and a doubling of platform revenue. The company reaffirmed its FY26 guidance amid ongoing macroeconomic caution.

Great Divide Mining has transitioned its Challenger Gold Mine in NSW from commissioning to commercial production, targeting a gold concentrate grade of 30 grams per tonne from historic tailings with minimal capital expenditure.

SciDev Ltd trims FY26 revenue guidance to $82-$87 million from $100-$110 million due to intensified competition in Energy Services and weather-related delays at Rum Jungle, while maintaining positive EBITDA and a confident FY27 outlook.

Qantas has sharply revised its FY26 outlook as jet fuel prices soar, doubling its international unit revenue growth forecast while trimming domestic capacity and deferring its share buyback.

Atomos Limited has obtained a new $10 million finance facility from Commonwealth Bank of Australia to support strategic growth initiatives and product development, while also reducing the cost of its existing loan. The company reconfirms its FY26 revenue and EBITDA guidance despite ongoing global uncertainties.

Telix Pharmaceuticals has announced FDA acceptance of its resubmitted NDA for TLX101-Px (Pixclara®), a PET imaging agent for glioma, setting a PDUFA goal date of September 11, 2026. The agent addresses a significant unmet need in distinguishing recurrent glioma from treatment effects.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Acrow Limited has reported record new hire contracts and a robust sales pipeline, confirming FY26 guidance and issuing optimistic initial guidance for FY27 revenue and earnings.

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

Austin Engineering has addressed ASX concerns over its half-year earnings, confirming compliance with disclosure rules despite downward revisions to FY26 guidance.

Life360 has delivered a landmark 2025 with record user growth, revenue, and profitability, driven by its expanding subscription base and new advertising ventures. The company’s transition to an AI-first platform and strategic acquisitions set the stage for ambitious growth in 2026.